Sanofi (SNY:NASDAQ) closed at $41.31 on October 20, 2026, up 4.38% on the day. The stock trades 21.6% below its 52-week high of $52.68 and 5.7% above its 52-week low of $39.07. Over the past year, it lost 20.4%. Sanofi is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since October 17, 2025, SNY closed higher on 125 days (50%). Its best day was June 4, 2026 (+4.74%) and its worst was May 4, 2026 (-5.92%). It never moved 10% or more in a single session.
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. The company offers a diverse array of drugs with its highest revenue generator, Lantus, representing just over 10% of total sales. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of sales.
Find more stocks like SNY with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.